Product Information
GABAPENTIN 400 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.0571 per EA under NDC 69097081512. Its NADAC has been published 421 times since Aug 10, 2016.
FDA first approved this application on Dec 30, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Cipla USA Inc.NDC
69097081512
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/21/2024
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA090705FDA Approved
12/30/2009
TE Code
AB
On Market Since
6/29/2016
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 400 MG CAPSULE has been published 421 times since Aug 10, 2016, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0571 per EA |
|---|---|
| All-time high | $0.0789 (Jan 16, 2019) |
| All-time low | $0.0463 (Jul 17, 2024) |
| Median price | $0.0646 |
| Average price | $0.0641 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 421 |
| Tracking since | Aug 10, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+2.6%
5Y
-9.0%
All
-23.4%
Last surveyed Aug 28, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 400 MG CAPSULE, manufactured by Cipla USA Inc., is $0.0571 per EA (NDC 69097081512), effective Aug 28, 2024.
How has the price of GABAPENTIN 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 400 MG CAPSULE has declined 23.4%. It has been tracked across 421 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 400 MG CAPSULE?
Since Aug 10, 2016, the NADAC for GABAPENTIN 400 MG CAPSULE has ranged from a low of $0.0463 (Jul 17, 2024) to a high of $0.0789 (Jan 16, 2019), with a median of $0.0646 per EA.
Are there cheaper alternatives to GABAPENTIN 400 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 400 MG CAPSULE, is $0.0400 per EA — about 30% below GABAPENTIN 400 MG CAPSULE.
Who manufactures GABAPENTIN 400 MG CAPSULE?
GABAPENTIN 400 MG CAPSULE (NDC 69097081512) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.